RxDoctor Payments Data

Darrell Thigpen

Internal Medicine · Dallas, TXNPI 1467468785

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations.

$1,390in general payments, 2019–2025

Across 93 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$149
  • Merck$140
  • Pfizer$137
  • Boehringer Ingelheim$130
  • Amarin Pharma, Inc.$122
  • Amgen$119
  • plus $593 from 14 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,390 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →